Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from RBC Capital

Nvidia To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Nvidia To Rally Around 69%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Is RDDT Stock a Buy, Sell, or Hold as Reddit Doubles Down on AI?

Reddit just doubled down on AI with two new advertising tools. After this announcement, is the stock a buy, sell, or hold now?

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Kinder Morgan Stock: Is Wall Street Bullish or Bearish?

Kinder Morgan has outpaced the broader market over the past year and analysts are reasonably upbeat about its future prospects.

Barchart

Planet Fitness, IBD Stock Of The Day, Flexes Near Buy Point With Membership Growth

Planet Fitness memberships rose despite the no-judgment gym operator's first fee hike in decades. Planet Fitness stock is near a buy point.

Investors Business Daily

3 Dividend Stocks to Buy Early in 2025, According to Analysts

Dividend stocks are known to offer the perfect mix of stability and growth. So, here are three top picks that Wall Street analysts recommend grabbing early in 2025 to maximize your returns.

Barchart

Key Takeaways From DexCom Analyst Ratings

DexCom (NASDAQ:DXCM) has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

The Latest Analyst Ratings For CME Gr

In the preceding three months, 18 analysts have released ratings for CME Gr (NASDAQ:CME), presenting a wide array of perspectives from bullish to bearish.

Benzinga

A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 19 Analysts

In the last three months, 19 analysts have published ratings on Vertex Pharmaceuticals (NASDAQ:VRTX), offering a diverse range of perspectives from bullish to bearish.

Benzinga

A Glimpse Into The Expert Outlook On Energy Transfer Through 4 Analysts

Energy Transfer (NYSE:ET) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

Benzinga

DocuSign Stock Jumps On Strong Q3, Analysts Await Proof Of Sustained Growth

DocuSign stock climbed on better-than-expected Q3 results and strong guidance for Q4 and fiscal 2025, leading to price target increases from analysts.

Benzinga

Cracking The Code: Understanding Analyst Reviews For Smartsheet

13 analysts have expressed a variety of opinions on Smartsheet (NYSE:SMAR) over the past quarter, offering a diverse set of opinions from bullish to bearish.

Benzinga

The Analyst Verdict: VSE In The Eyes Of 7 Experts

Ratings for VSE (NASDAQ:VSEC) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

Benzinga

Key Takeaways From IDEX Analyst Ratings

Throughout the last three months, 4 analysts have evaluated IDEX (NYSE:IEX), offering a diverse set of opinions from bullish to bearish.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Key Takeaways From WESCO Intl Analyst Ratings

8 analysts have shared their evaluations of WESCO Intl (NYSE:WCC) during the recent three months, expressing a mix of bullish and bearish perspectives.

Benzinga

Expert Outlook: Atkore Through The Eyes Of 6 Analysts

Atkore (NYSE:ATKR) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

Benzinga

Decoding 6 Analyst Evaluations For Pacira BioSciences

Across the recent three months, 6 analysts have shared their insights on Pacira BioSciences (NASDAQ:PCRX), expressing a variety of opinions spanning from bullish to bearish.

Benzinga

Unveiling 13 Analyst Insights On Clearwater Analytics Hldg

Across the recent three months, 13 analysts have shared their insights on Clearwater Analytics Hldg (NYSE:CWAN), expressing a variety of opinions spanning from bullish to bearish.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Decoding 17 Analyst Evaluations For Honeywell Intl

Analysts' ratings for Honeywell Intl (NASDAQ:HON) over the last quarter vary from bullish to bearish, as provided by 17 analysts.

Benzinga

Decoding 16 Analyst Evaluations For Global Payments

Global Payments (NYSE:GPN) underwent analysis by 16 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

Benzinga

Evaluating Globus Medical: Insights From 11 Financial Analysts

Globus Medical (NYSE:GMED) has been analyzed by 11 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

Benzinga

Analyst Ratings For PagerDuty

Providing a diverse range of perspectives from bullish to bearish, 12 analysts have published ratings on PagerDuty (NYSE:PD) in the last three months.

Benzinga

The Analyst Verdict: Edwards Lifesciences In The Eyes Of 17 Experts

Analysts' ratings for Edwards Lifesciences (NYSE:EW) over the last quarter vary from bullish to bearish, as provided by 17 analysts.

Benzinga

Unveiling 12 Analyst Insights On Charter Communications

Ratings for Charter Communications (NASDAQ:CHTR) were provided by 12 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

Benzinga

Exxon Mobil Unusual Options Activity For November 26

Deep-pocketed investors have adopted a bearish approach towards Exxon Mobil (NYSE:XOM), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in XOM usually suggests something big is…

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.